China Healthcare Summit
November 2-3, 2023 | Shanghai

November 7-8, 2023 | Digital

BioCentury and BayHelix’s China Healthcare Summit marks its 10th Anniversary with a return to Shanghai, gathering C-level executives from Asia and beyond for renewed cross-border collaboration and discussion. Innovation from Asian biotechs is on the rise, presenting new opportunities for partnership and investment. China Summit is specifically tailored for C-level executives and VCs, with a strategic program offering a first-hand look at the innovation, business, and policy transformations taking place in China and Asia. Don’t miss this opportunity to join your peers in-person in Shanghai Nov. 2-3, and for an additional 2 days of virtual meetings from Nov. 7-8, to explore transformative opportunities with global reach.

---

Written by Richard Daverman, PhD. Click a link below to view the mailing archive as if it had been sent to you. 2014-01-31 01:30 Mindray Medical Acquires US-China IVD Company 2014-01-30 01:30 BioTime Starts US-China Test of Cancer Diagnostic and more... 2014-01-29 01:30 Actavis Sells China JV to Zhejiang Chiral Medicine and more... 2014-01-28 01:30 Wanbang In-licenses Diabetes Drug Rights from Sirona of Canada 2014-01-26 01:30 Week in Review: Zhejiang Wolwo Bio-Pharm Stages $84 Million Shenzhen IPO 2014-01-25 01:30 Zhejiang Wolwo Bio-Pharma Gains 94% Post-IPO 2014-01-24 01:30 Big Four Accounting Firms Face Six-Month Suspension in China and more... 2014-01-23 01:30 Abcam of the UK Opens Shanghai Office 2014-01-22 01:30 Harbin Gloria Pharma In-licenses China Rights to Korean Drug 2014-01-21 01:30 TaiGen Raises $36 Million in Taiwan IPO 2014-01-19 01:30 Week in Review: Jiangsu Aosaikang Pharma Delays China IPO 2014-01-18 01:30 China Adds Regs to New IPO Process and more... 2014-01-17 01:30 Actavis to Leave China and more... 2014-01-16 01:30 GSK Says China Revenues Recovered in Q4 and more... 2014-01-15 01:30 Covidien Forms China JV to Address ?óÔé¼?ôValue?óÔé¼?Ø Market and more... 2014-01-14 01:30 Jiangsu ASK Pharma Postpones ChiNext IPO and more... 2014-01-12 01:30 Week in Review: Eddingpharm Buys ACT Biotech Assets for $95 Million 2014-01-11 01:30 Kunshan RiboQuark Raises $7.5 Million for siRNA Projects and more... 2014-01-10 01:30 China Revokes J&J's Trademark for OneTouch Diabetes Monitoring Products and more... 2014-01-09 01:30 Eddingpharm Acquires ACT Biotech for $95 Million and more... 2014-01-08 01:30 Asia Registers Big Gain in Global Pharma R&D Spending; US Drops and more... 2014-01-07 01:30 China Announces Blacklist for Medical Bribery and Substandard Products and more... 2014-01-05 01:30 Week in Review: China Starting Up Revamped IPO System 2014-01-04 01:30 China Restarts IPO Process and more... 2014-01-03 01:30 Stellar Biotech Collaborates with Amaran Biotech/OBI Pharma and more... 2014-01-01 01:30 DIH Medical Technologies In-licenses China Rights to Stroke Recovery Device   << Archive Index • Subscribe >>   Subscription preference center Archive Powered by FeedBlitz Not a ChinaBio®Today Subscriber? Here's what you get with a paid subscription to ChinaBio® Today: Website access to all current articles and commentary Full access to over 2000 archived articles on the biotech industry Get started now for as little as $20... ChinaBio and ChinaBio Today are trademarks of ChinaBio LLC